WO2000053735A3 - Methods for identifying modulators of synaptic plasticity and cell motility - Google Patents

Methods for identifying modulators of synaptic plasticity and cell motility Download PDF

Info

Publication number
WO2000053735A3
WO2000053735A3 PCT/IB2000/000505 IB0000505W WO0053735A3 WO 2000053735 A3 WO2000053735 A3 WO 2000053735A3 IB 0000505 W IB0000505 W IB 0000505W WO 0053735 A3 WO0053735 A3 WO 0053735A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
cell motility
synaptic plasticity
candidate compound
identifying modulators
Prior art date
Application number
PCT/IB2000/000505
Other languages
French (fr)
Other versions
WO2000053735A9 (en
WO2000053735A2 (en
Inventor
Stephen Morris
Richard Murphy
James Fawcett
Timothy Kennedy
Colleen Mannit
Original Assignee
Univ Mcgill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill filed Critical Univ Mcgill
Priority to AU36676/00A priority Critical patent/AU3667600A/en
Publication of WO2000053735A2 publication Critical patent/WO2000053735A2/en
Publication of WO2000053735A3 publication Critical patent/WO2000053735A3/en
Publication of WO2000053735A9 publication Critical patent/WO2000053735A9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5029—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Abstract

The invention features a method for determining whether a candidate compound modulates the expression of a gene operably linked to a netrin promoter, including: a) providing a cell expressing a gene operably linked to a netrin promoter; b) contacting the cell with a candidate compound; c) detecting or measuring expression of the gene following contact of the cell with the candidate compound; and d) determining whether the candidate compound modulates the expression of the gene.
PCT/IB2000/000505 1999-03-10 2000-03-09 Methods for identifying modulators of synaptic plasticity and cell motility WO2000053735A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU36676/00A AU3667600A (en) 1999-03-10 2000-03-09 Methods for identifying compounds that modulate synaptic plasticity and cell motility

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12363699P 1999-03-10 1999-03-10
US60/123,636 1999-03-10

Publications (3)

Publication Number Publication Date
WO2000053735A2 WO2000053735A2 (en) 2000-09-14
WO2000053735A3 true WO2000053735A3 (en) 2000-12-28
WO2000053735A9 WO2000053735A9 (en) 2002-08-29

Family

ID=22409885

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2000/000505 WO2000053735A2 (en) 1999-03-10 2000-03-09 Methods for identifying modulators of synaptic plasticity and cell motility

Country Status (2)

Country Link
AU (1) AU3667600A (en)
WO (1) WO2000053735A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005275062A1 (en) 2004-07-14 2006-02-23 University Of Utah Research Foundation Netrin-related compositions and uses
EP3037817B1 (en) * 2013-08-19 2019-06-12 Osaka University Screening method for pain suppressors and pharmaceutical composition for prevention or treatment of pain

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824775A (en) * 1996-04-19 1998-10-20 The Regents Of The University Of California Human netrin-1
US5939271A (en) * 1997-02-19 1999-08-17 The Regents Of The University Of California Netrin receptor
WO1999061585A1 (en) * 1998-05-22 1999-12-02 University Technology Corporation Assays for identifying anti-metastatic and neurite-promoting agents and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824775A (en) * 1996-04-19 1998-10-20 The Regents Of The University Of California Human netrin-1
US5939271A (en) * 1997-02-19 1999-08-17 The Regents Of The University Of California Netrin receptor
WO1999061585A1 (en) * 1998-05-22 1999-12-02 University Technology Corporation Assays for identifying anti-metastatic and neurite-promoting agents and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
COLAMARINO, C. AND TESSIER-LAVIGNE, M.: "The axonal chemoattractant Netrin-1 is also a chemorepellent for trochlear motor axons", CELL, vol. 81, May 1995 (1995-05-01), pages 621 - 629, XP002147485 *
KENNEDY T E ET AL: "NETRINS ARE DIFFUSIBLE CHEMOTROPIC FACTORS FOR COMMISSURAL AXONS IN THE EMBRYONIC SPINAL CORD", CELL,US,CELL PRESS, CAMBRIDGE, NA, vol. 78, 12 August 1994 (1994-08-12), pages 425 - 435, XP002017868, ISSN: 0092-8674 *
MING, G-L. ET AL: "Phospholipase C-gamma and phosphoinositide 3-kinase mediate cytoplasmic signalling in nerve growth cone guidance", NEURON, vol. 23, May 1999 (1999-05-01), pages 139 - 148, XP000946117 *

Also Published As

Publication number Publication date
WO2000053735A9 (en) 2002-08-29
WO2000053735A2 (en) 2000-09-14
AU3667600A (en) 2000-09-28

Similar Documents

Publication Publication Date Title
WO2002097415A3 (en) Analytical instruments, biosensors and methods
WO2002097414A3 (en) Analytical instruments and biosensors, and methods for increasing their accuracy and effective life
DK1495330T3 (en) Method of Identifying Compounds Affecting Transmembrane Proteins
PT922226E (en) PROCESS FOR THE EVALUATION OF THE STATE OF AN ORGANISM THROUGH PEPTIDE MEDICATION
WO2002095070A3 (en) Polynucleotide sequencing method
AU2610101A (en) Methods and systems for monitoring intracellular binding reactions
PL360130A1 (en) Method of diagnosing cardiac muscle attack, set of reagents for diagnosing cardiac muscleattack and use of such set of reagents
EP0759028A4 (en) Method of detecting prions in a sample and transgenic animal used for same
WO2004046687A3 (en) Methods of biosensing using fluorescent polymers and quencher-tether-ligand bioconjugates
ATE510214T1 (en) DISEASE DIAGNOSIS
WO2003027634A3 (en) Identification of modulatory molecules using inducible promoters
DE59914830D1 (en) METHOD AND TEST ASSAY FOR ASSESSING THE OXID MEASUREMENT OF THEIR ANTIRADIC ACTIVITY
CA2289043A1 (en) Method for detecting or predicting ischemic disorders
WO1999024611A3 (en) Analyte detection process using dual labeled probes
WO2000053735A3 (en) Methods for identifying modulators of synaptic plasticity and cell motility
CA2407760A1 (en) Methods for diagnosis of low grade astrocytoma
WO2001083816A3 (en) Method for detecting tumors
WO2001042503A3 (en) Apparatus and methods for drug screening based on nucleic acid analysis
WO2004078783A3 (en) Enzymes involved in apoptosis
AU3571901A (en) Electrochemical method for detecting nucleic acids
AU2606800A (en) Methods of determining an increased risk of a woman carrying a downs syndrome
WO1999015659A3 (en) Human ubiquitin-conjugating enzymes
ATE359513T1 (en) HIGH-THROUGHPUT SCREENING OF COMPOUNDS FOR BIOLOGICAL EFFECTIVENESS
AU3118300A (en) Cartilage resorption assays
WO2005057220A3 (en) Agents modulating the activity of ccrl2 and methods of using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP NZ

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP NZ

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
AK Designated states

Kind code of ref document: C2

Designated state(s): AU CA JP NZ

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGE 18, DESCRIPTION, REPLACED BY A NEW PAGE 18; AFTER RECTIFICATION OF OBVIOUS ERRORS AS AUTHORIZED BY THE INTERNATIONAL SEARCHING AUTHORITY